Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
After investing in their Series B, Lilly bags a license for a batch of metabolic candidates
4 years ago
Deals
CVS takes a swing at Bristol Myers and Pfizer, excluding coverage of their megablockbuster Eliquis in 2022
4 years ago
Pharma
The latest healthcare SPAC comes in at $200M with a laser focus on artificial intelligence
4 years ago
Financing
AI
Roche offers an upbeat two-plus-year look at its anti-TIGIT combo therapy — but will two deaths hurt its chances?
4 years ago
R&D
Dekkers-founded investment firm Novalis LifeSciences raises $300M for second fund and adds to the team
4 years ago
Financing
Oversight Committee unleashes scathing drug pricing report as Senate preps to vote on allowing Medicare negotiations
4 years ago
Pharma
As Biohaven CEO Coric preps FDA filing for new migraine spray, he's already scouting for celebrity spokesperson
4 years ago
Pharma
Marketing
Moderna says its mRNA flu vaccine cleared early studies, but comparisons with other vaccines drive stock down
4 years ago
R&D
Covid-19 roundup: UK preps for a wave of Omicron cases; Bourla suggests a fourth dose might be necessary
4 years ago
Coronavirus
Snakebit Angion reports another miss for lead program, as biotech prepares to shift its 'primary focus'
4 years ago
R&D
Billionaire BioNTech backers have been kicking the tires at Novartis' big generics arm — report
4 years ago
Deals
Bioregnum
Flagship on center stage: Axcella’s new CMO likens the biotech to ‘professional sports team’; Life after the ...
4 years ago
Peer Review
GlaxoSmithKline enlisted Harris Poll for a severe asthma survey — results point to more outreach
4 years ago
Pharma
Marketing
Viatris and Biocon mull pooling their biosimilars into a $10B standalone company — report
4 years ago
Deals
Kenya to reduce import dependency with production of new site; Co-laboratory space to open in China
4 years ago
Manufacturing
Recall report: Sandoz yanks 1 lot of enoxaparin after exposure to warm temperatures
4 years ago
Manufacturing
Ever optimistic despite concerns, BrainStorm teams with Catalent to prep for possible approval for ALS drug
4 years ago
Cell/Gene Tx
Manufacturing
Fujifilm cracks open doors at its newest drug production site in the Netherlands
4 years ago
Manufacturing
Taipei's Bora wants in on the CDMO game as report shows plenty of room for industry growth
4 years ago
Cell/Gene Tx
Manufacturing
Merck enlists Thermo Fisher to make Covid-19 antiviral molnupiravir for Canada, UK
4 years ago
Manufacturing
Covid-19 manufacturing roundup: Covax, Indian manufacturer at odds over vaccine supply; EU planning surplus on shot ...
4 years ago
Coronavirus
Manufacturing
Totus pulls in $40M Series A with sights on PI3Kα; FDA asks Sesen for another trial after CRL, biotech says
4 years ago
News Briefing
Eir Ventures tops up life sciences fund with $138M for Nordic biotechs
4 years ago
Financing
With new pivotal data, uniQure and CSL Behring dash to the FDA with a potential blockbuster gene therapy for ...
4 years ago
R&D
Cell/Gene Tx
First page
Previous page
611
612
613
614
615
616
617
Next page
Last page